KKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
KKR is not a clear buy right now for a Beginner investor focused on the long term with $50,000-$100,000 to invest. The stock has mixed signals: hedge funds and congress members are buying, but the technical trend is still weak, options sentiment is bearish, and analysts are split between Buy/Outperform and Hold with recent price target trims. Because the user wants to act now rather than wait for a better entry, this is still not the best immediate purchase. My direct view: hold off for a cleaner setup.
KKR is in a short-term bearish posture. MACD histogram is negative at -0.605, RSI_6 at 34.934 is weak but not deeply oversold, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 94.12 is below the pivot of 95.619 and only modestly above support at 92.015, with resistance at 99.223. The setup suggests downside pressure remains unless the stock reclaims the pivot and short-term moving averages.
Hedge funds are strongly buying, with buying up 604.51% over the last quarter. Congress trading is also positive, with 2 purchase transactions and no sales in the last 90 days. News also shows KKR expanding internationally with a new Milan office and continued deployment in Italy, which supports long-term franchise growth.
Recent news includes KKR and ECP withdrawing the £5.5 billion DCC bid, which may raise concern about execution or deal environment. The company also faces pressure around FS KKR losses tied to poor investment performance. Technically, the stock is weak, and historical pattern analysis suggests an 80% chance of short-term declines over the next day and week.
No usable latest-quarter financial snapshot was provided due to an error, so a detailed quarter-by-quarter financial read is not available here. From the analyst commentary, Q1 was described as solid with better carry and realized investment income, but some of that strength was helped by lumpy items and may not be fully repeatable. The latest quarter season referenced is Q1 2026.
Analyst sentiment is mixed. Several firms kept Buy/Outperform ratings and raised targets, including UBS to $126 and Oppenheimer to $143, while TD Cowen kept Hold and lowered its target to $104. Recent target changes show some optimism about long-term earnings power and valuation, but also caution around current earnings quality and mixed Q1 revisions. Overall Wall Street is constructive on the franchise long term, but not uniformly bullish at current levels.
